• Explore /
  • Poster
  • / Hepatic artery infusion chemotherapy (HAIC) combined with apatinib and camrelizumab for hepatocellular carcinoma (HCC) in BCLC stage c: A prospective, single-arm, phase II trial (TRIPLET study).

Hepatic artery infusion chemotherapy (HAIC) combined with apatinib and camrelizumab for hepatocellular carcinoma (HCC) in BCLC stage c: A prospective, single-arm, phase II trial (TRIPLET study).

Abstract Poster

Authors

null

Yang-Kui Gu

Department of Minimally Invasive Interventional Radiology, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China

Yang-Kui Gu , Tian-Qi Zhang , Meng-Xuan Zuo , Zhi-Jun Geng , Ji-Bin Li , Zi-Lin Huang , Pei-Hong Wu

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Hepatobiliary Cancer

Clinical Trial Registration Number

NCT04191889

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 4106)

DOI

10.1200/JCO.2022.40.16_suppl.4106

Abstract #

4106

Poster Bd #

93

Abstract Disclosures

Similar Posters

First Author: Xu Yunxiuxiu

First Author: Yongkang Xu

First Author: Gong-Rang Chen

First Author: MinKe He